# Gabriele Campi

> Gabriele Campi is a Series B investor at Aurora Science backing Therapeutics and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Aurora Science](https://shizune.co/investors/profile/aurora-science)
- Location: Milan, Italy
- Total investments: 1
- Last investment: Feb 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gabrielecampi/

Gabriele Campi is a Series B investor at Aurora Science in Milan focused on Therapeutics and Biotechnology. Gabriele Campi is the Board Member at InteRNA Technologies. Gabriele Campi attended SAE Institute Milan.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Information Technology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| InteRNA Technologies | InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatmentNijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investorsparticipating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels. | $22.4M | Series B | Feb 09, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Aglaia BioMedical Ventures](https://shizune.co/investors/profile/aglaia-biomedical-ventures) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [OostNL](https://shizune.co/investors/profile/oostnl) — VC Fund, 1 deal together

## About Aurora Science

VC Fund · Milano, Italy

AurorA Science is a biotech investment company integrating an innovative financial and industrial approach in the research and development challenges. The company is focused on independent and entrepreneurial biotech start-ups in Europe with high therapeutic potential, providing industrial and financial support.

1 contacts available at Aurora Science.

| Name | Title | Profile |
| --- | --- | --- |
| Gabriele Campi | Co-Founder & Managing Partner | https://shizune.co/investors/profile/gabriele-campi |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Gabriele Campi invest in?

Gabriele Campi invests primarily in Therapeutics, Biotechnology and Information Technology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gabriele Campi last invest?

The most recent investment recorded for Gabriele Campi closed in Feb 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co